Dr. Gunjan Bhardwaj is the founder and CEO of Innoplexus AG. With the help of artificial intelligence, blockchain and big data analysis applications, its iPlexus software has crawled over 300...
Read More
With a dramatic rise in physician burnout and many physicians exiting the field prematurely, the health care industry is looking to artificial intelligence (AI) to provide much needed support. AI can...
Read More
It’s no surprise that the public hates Big Pharma. They rank just under the government on most Americans’ despised institution list. ...
Read More
Innoplexus is at the forefront of decision-making technology as the company works in data aggregation to provide to...
Read More
We are in the midst of a significant shift in pharmaceutical drug development, with many leading companies focusing increasingly on orphan drugs targeted at small niche markets. An orphan disease is...
Read More
Companies that thrive on sustaining products over a long period are always at risk of classic disruptive innovation—losing business to a smaller company with fewer resources that jumps in, improves...
Read More
The idea that a company’s success depends on how much it can leverage the skills of its employees’ bright minds is rapidly becoming an outdated concept. Companies that are equipped...
Read More
Redundancies in any professional field mean dollars lost. But in healthcare, inefficiency can cost lives. That’s a reality that Gunjan Bhardwaj came to understand when his friend and mentor was diagnosed...
Read More
In this special guest feature, Gunjan Bhardwaj, Founder and CEO of Innoplexus, discusses how data silos in pharma prevent the latest advancements in machine learning and data analytics from operating...
Read More
Researchers tend to have a genuine scientific curiosity and desire to make the world better with their discoveries. They are often thrilled about laboratory experiments and preclinical studies, regardless of...
Read More
